| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Moran Timothy P. | Chief Business Officer | C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND | /s/ Traci S. Umberger as attorney-in-fact for Timothy P. Moran | 04 Dec 2025 | 0001753958 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KMTS | Common Shares | Award | +19,557 | 19,557 | 03 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date. |